Dr. Deborah Dunsire has been named president and chief executive officer of EnVivo Pharmaceuticals and joins the company’s board of directors. Dr. Dunsire brings more than 25 years of scientific, clinical, operational and commercial experience in the pharma and biopharma industries.   Dr. Dunsire joins the company from Millennium, The Takeda Oncology Company, where she served as president and chief executive officer from 2005 to 2013. During that period, she led R&D, driving the development ...